Skip to main content
. 2012 Sep 12;2012(9):CD001901. doi: 10.1002/14651858.CD001901.pub2

6. Quality of Life (QOL) assessment as mean change from baseline (QOLIE‐31): Zhou 2008.

Subscale Placebo (n=11) Lev 3g/d (n=13)
Overall QOL Improved Improved
Seizure worry Improved Improved
Emotional well‐being Improved Improved
Energy‐fatigue Improved worsened
Cognitive functioning Worsened IMPROVED*
Medication effects Worsened Improved
Social function Improved IMPROVED*
Health status Improved Improved
     
Note: ( * ) p‐value < 0.01